- Previous Close
10.30 - Open
10.25 - Bid --
- Ask --
- Day's Range
9.06 - 10.25 - 52 Week Range
5.01 - 11.80 - Volume
64,916 - Avg. Volume
338,498 - Market Cap (intraday)
1.076B - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
10.99 - EPS (TTM)
0.91 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Oct 7, 2008
- 1y Target Est
12.75
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
veradigm.com8,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MDRX
View MorePerformance Overview: MDRX
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MDRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MDRX
View MoreValuation Measures
Market Cap
1.08B
Enterprise Value
1.08B
Trailing P/E
11.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
0.87
Enterprise Value/Revenue
0.49
Enterprise Value/EBITDA
2.49
Financial Highlights
Profitability and Income Statement
Profit Margin
3.97%
Return on Assets (ttm)
2.16%
Return on Equity (ttm)
8.93%
Revenue (ttm)
1.53B
Net Income Avi to Common (ttm)
115.91M
Diluted EPS (ttm)
0.91
Balance Sheet and Cash Flow
Total Cash (mrq)
492.6M
Total Debt/Equity (mrq)
18.59%
Levered Free Cash Flow (ttm)
155.57M